STAT+ Conversations
Pop-up virtual events featuring our reporters and leading industry experts. They’ll take the opportunity to dive deep into the story of the moment. Check out the registration page to see what’s next.
Most Read
STAT+ Conversation: Selling Cellarity
STAT+ Conversation: What’s next in gene therapy
STAT+ Conversation: Which biotech venture capital funds performed best during the pandemic?
STAT+ Conversation: Theranos returns
STAT+ Conversation: Dealing with the Delta variant
STAT+ Conversations: A conversation on scrutiny facing Epic’s health care algorithms
STAT+ Conversations: A conversation about in vivo gene editing to treat rare disease
All Coverage
advertisement